Vaxart (VXRT) Misses Q4 EPS by 23c

Vaxart (NASDAQ: VXRT) reported Q4 EPS of ($0.33), $0.23 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $28.7 million versus the consensus estimate of $20.77 million.

For earnings history and earnings-related data on Vaxart (VXRT) click here.

You May Also Be Interested In

• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
• HDFC Asset Management Co Ltd (HDFCAMC:IN) PT Raised to INR3,250 at JPMorgan
• Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)